Literature DB >> 29157401

Multiple Sclerosis in the Contemporary Age: Understanding the Millennial Patient with Multiple Sclerosis to Create Next-Generation Care.

Madison R Hansen1, Darin T Okuda2.   

Abstract

The average age of onset of multiple sclerosis (MS) is between 20 and 40 years of age. Therefore, most new patients diagnosed with MS within the next 10 to 15 years will be from the millennial generation, representing those born between 1982 and 2000. Certain preferences and trends of this contemporary generation will present new challenges to the MS physician and effective MS care. By first understanding these challenges, relevant and successful solutions can be created to craft a system of care that best benefits the millennial patient with MS.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Baby boomers; Generation X; Millennials; Mobile applications; Multiple sclerosis; Telehealth; Telemedicine

Mesh:

Year:  2018        PMID: 29157401     DOI: 10.1016/j.ncl.2017.08.012

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  4 in total

1.  Functional and self-care capacity of people with multiple sclerosis.

Authors:  Ana Railka de Souza Oliveira-Kumakura; Larissa Maria Bezutti; Juliany Lino Gomes Silva; Renata Cristina Gasparino
Journal:  Rev Lat Am Enfermagem       Date:  2019-10-07

2.  3MD for Chronic Conditions, a Model for Motivational mHealth Design: Embedded Case Study.

Authors:  Guido Giunti
Journal:  JMIR Serious Games       Date:  2018-08-24       Impact factor: 4.143

3.  A Web-Based Survey Assessing the Attitudes of Health Care Professionals in Germany Toward the Use of Telemedicine in Pregnancy Monitoring: Cross-Sectional Study.

Authors:  Niklas Grassl; Juliane Nees; Katharina Schramm; Julia Spratte; Christof Sohn; Timm C Schott; Sarah Schott
Journal:  JMIR Mhealth Uhealth       Date:  2018-08-08       Impact factor: 4.773

4.  The FTO gene polymorphism rs9939609 is associated with obesity and disability in multiple sclerosis patients.

Authors:  Ahmad Al-Serri; Raed Alroughani; Rabeah A Al-Temaimi
Journal:  Sci Rep       Date:  2019-12-13       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.